Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Huang, Chi Jung ^a   Wu, Chih Feng ^a   Lan, Chia Ying ^a   Sung, Feng Yu ^a   Lin, Chih Lin ^b   Liu, Chun Jen ^c   Liu, Hsin Fu ^d   Yu, Ming Whei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B VIRUS POLYMERASE; HEPATITIS B(E) ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; UNINDEXED SEQUENCE; VIRAL CLEARANCE; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GENES, VIRAL; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL LOAD; VIRULENCE;

EID: 84880783663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070169     Document Type: Article

References (31)

1. Liaw YF, Chu CM, (2009) Hepatitis B virus infection. Lancet 373: 582-592.
2. Locarnini S, (2004) Molecular virology of hepatitis B virus. Semin Liver Dis 24Suppl 1: 3-10.
3. Kay A, Zoulim F, (2007) Hepatitis B virus genetic variability and evolution. Virus Res 127: 164-176.
4. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY, (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80: 10307-10314.
5. Thompson A, Locarnini S, Visvanathan K, (2007) The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations? Gastroenterology 133: 1031-1035.
6. Poropatich K, Sullivan DJ Jr, (2011) Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol 92: 247-268.
7. Moore CB, John M, James IR, Christiansen FT, Witt CS, et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
8. Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, et al. (2007) Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 3: e29.
9. Ramachandran S, Campo DS, Dimitrova ZE, Xia GL, Purdy MA, et al. (2011) Temporal variations in the hepatitis C virus intrahost population during chronic infection. J Virol 85: 6369-6380.
10. Merani S, Petrovic D, James I, Chopra A, Cooper D, et al. (2011) Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology 53: 396-405.
11. Desmond CP, Bartholomeusz A, Gaudieri S, Revill PA, Lewin SR, (2008) A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir Ther 13: 161-175.
12. Wu CF, Yu MW, Lin CL, Liu CJ, Shih WL, et al. (2008) Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 29: 106-112.
13. Sung FY, Jung CM, Wu CF, Lin CL, Liu CJ, et al. (2009) Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology 137: 1687-1697.
14. Fattovich G, Bortolotti F, Donato F, (2008) Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48: 335-352.
15. Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, et al. (2008) An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One 3: e2573.
16. Yuen MF, Yuan HJ, Hui CK, Wong DK, Wong WM, et al. (2003) A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 52: 416-419.
17. Rauch A, James I, Pfafferott K, Nolan D, Klenerman P, et al. (2009) Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 50: 1017-1029.
18. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, et al. (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97: 265-272.
19. Lim SG, Cheng Y, Guindon S, Seet BL, Lee LY, et al. (2007) Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology 133: 951-958.
20. Wu S, Imazeki F, Kurbanov F, Fukai K, Arai M, et al. (2011) Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. J Hepatol 54: 19-25.
21. Huang HH, Shih WL, Li YH, Wu CF, Chen PJ, et al. (2011) Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway. Gut 60: 99-107.
22. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, et al. (2000) The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191: 1269-1280.
23. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, et al. (2008) Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205: 1009-1017.
24. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, et al. (2008) Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4: e1000033.
25. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, et al. (2005) Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725-1731.
26. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, et al. (1994) Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68: 2671-2676.
27. Chou YC, Yu MW, Wu CF, Yang SY, Lin CL, et al. (2008) Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 57: 91-97.
28. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, et al. (2007) Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133: 843-852.
29. Bertoletti A, Gehring AJ, (2006) The immune response during hepatitis B virus infection. J Gen Virol 87: 1439-1449.
30. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, et al. (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
31. Torresi J, (2002) The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 25: 97-106.